FDA Inspection
KRS Global Biotechnology, IncKRS Global Biotechnology, Inc – FDA Inspection, Aug 31, 2016
Record Details
This FDA Inspection record concerns KRS Global Biotechnology, Inc, with an inspection on August 31, 2016, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 31, 2016
- Product Type
- Drugs
View Company Profile
ID · cd85867a-e3de-43ab-81cd-ce981ec9d9d8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 986013
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
6- 21 CFR 211.42(c)(10)(iii)Air Supply
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.42(c)(10)(iv)Environmental Monitoring System
- 21 CFR 211.28(a)Clothing appropriate for duties performed
- 21 CFR 211.113(b)Procedures for sterile drug products
- Drug product label, outsourcer facility
Full citation text and observation details available on the Dashboard.
Other FDA inspections of KRS Global Biotechnology, Inc
3| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 23, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 17, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for KRS Global Biotechnology, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.